Nigerian Scientist Wins Global HIV Research Grant

Dr. Adam Abdullahi, a Nigerian infectious disease and global health scientist, has been awarded the CIPHER (Collaborative Initiative for Paediatric HIV Education and Research) Grant by the International AIDS Society (IAS). The grant, valued at up to $150,000 over two years, was awarded to four researchers worldwide from more than 1,000 applicants. Dr. Abdullahi is […]

Dr. Adam Abdullahi, a Nigerian infectious disease and global health scientist, has been awarded the CIPHER (Collaborative Initiative for Paediatric HIV Education and Research) Grant by the International AIDS Society (IAS).

The grant, valued at up to $150,000 over two years, was awarded to four researchers worldwide from more than 1,000 applicants. Dr. Abdullahi is one of two African recipients in this cycle.

His research will focus on drug resistance among children and adolescents on dolutegravir (DTG)-based treatment in sub-Saharan Africa. The study aims to map resistance patterns, generate evidence for treatment optimization, and improve outcomes for young people living with HIV.

Dr. Abdullahi has previously conducted work on vaccine science, epidemic preparedness, and health systems. He is a former Harvard Takemi Fellow and Research Associate at the University of Cambridge. His past research has included studies on SARS-CoV-2 vaccine immunogenicity in West Africa and on Mpox transmission risks in Nigeria.

Nigeria faces a significant paediatric HIV burden. The country has the second-largest population of children living with HIV globally, with only 26% on antiretroviral therapy as of 2017. In the same year, Nigeria accounted for nearly 30% of new infections in West and Central Africa.

Speaking on the grant, Dr. Abdullahi said African researchers must take ownership of evidence generation and treatment strategies to address HIV within local contexts.

The award highlights the continuing need for investment in locally driven research on infectious diseases in Nigeria and across Africa.